FGF23 and chronic kidney disease: CKD leads to a consequent increase in parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF23), mainly produced by osteoblasts and osteocytes, which inhibits phosphate tubular reabsorption, reduces 1α-hydroxylase activity and calcitriol levels [2].